Vermillion to Present at the Canaccord Genuity 37th Annual Growth Conference on August 10th

12:03 EDT 1 Aug 2017 | PR Newswire

AUSTIN, Texas, Aug. 1, 2017 /PRNewswire/ -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that Valerie Palmieri, President and Chief Executive Officer, will provide a corporate overview at the Canaccord Genuity 37th Annual Growth Conference, being held August 9-10 in Boston, Massachusetts.

Presentation Details


Thursday, August 10


1:00pm Eastern Time


InterContinental Boston Hotel, Hong Kong Room

About VermillionVermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with critical disease improve their overall health outcomes.

Investor Relations Contact:Michael Wood
LifeSci Advisors LLC

View original content:

SOURCE Vermillion, Inc.


More From BioPortfolio on "Vermillion to Present at the Canaccord Genuity 37th Annual Growth Conference on August 10th"

Quick Search

Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...